Hartl L; Jachs M; Simbrunner B; Bauer DJM; Semmler G; Gompelmann D; Szekeres T; Quehenberger P; Trauner M; Mandorfer M; Scheiner B; Reiberger T, 2021. Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19. J Pers Med 11.
Semmler G; Binter T; Kozbial K; Schwabl P; Chromy D; Bauer D; Simbrunner B; Müllner-Bucsics T; Scheiner B; Stättermayer A; Pinter M; Steindl-Munda P; Trauner M; Ferenci P; Reiberger T; Mandorfer M, 2021. Influence of Genetic Variants on Disease Regression and Outcomes in HCV-Related Advanced Chronic Liver Disease after SVR. J Pers Med 11.
Semmler G; Binter T; Kozbial K; Schwabl P; Hametner-Schreil S; Zanetto A; Gavasso S; Chromy D; Bauer DJM; Simbrunner B; Scheiner B; Bucsics T; Stättermayer AF; Pinter M; Steindl-Munda P; Schöfl R; Russo FP; Simioni P; Trauner M; Ferenci P; Reiberger T; Mandorfer M, 2021. Noninvasive Risk Stratification After HCV Eradication in Patients With Advanced Chronic Liver Disease. Hepatology 73(4):1275-1289
Bauer D; Farthofer A; Chromy D; Simbrunner B; Steininger L; Schmidbauer C; Binter T; Trauner M; Mandorfer M; Schmidt R; Mayer F; Holzmann H; Strassl R; Reiberger T, 2021. Recent outbreaks of severe hepatitis A virus infections in Vienna. Eur J Clin Microbiol Infect Dis 40(2):335-344
Simbrunner B; Stadlmann A; Schwabl P; Paternostro R; Bauer DJM; Bucsics T; Scheiner B; Lampichler K; Wöran K; Beer A; Eigenbauer E; Pinter M; Stättermayer AF; Marculescu R; Szekeres T; Trauner M; Mandorfer M; Reiberger T, 2021. Placental growth factor levels neither reflect severity of portal hypertension nor portal-hypertensive gastropathy in patients with advanced chronic liver disease. Dig Liver Dis 53(3):345-352
Burghart L; Halilbasic E; Schwabl P; Simbrunner B; Stättermayer AF; Petrenko O; Scheiner B; Bauer D; Pinter M; Boztug K; Mandorfer M; Trauner M; Reiberger T, 2021. Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis. J Gastroenterol.
Jachs M; Hartl L; Schaufler D; Desbalmes C; Simbrunner B; Eigenbauer E; Bauer DJM; Paternostro R; Schwabl P; Scheiner B; Bucsics T; Stättermayer AF; Pinter M; Trauner M; Mandorfer M; Reiberger T, 2021. Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes. Gut 70(9):1758-1767
Paternostro R; Bardach C; Hofer BS; Scheiner B; Schwabl P; Asenbaum U; Ba-Ssalamah A; Scharitzer M; Bucscis T; Simbrunner B; Bauer D; Trauner M; Mandorfer M; Reiberger T; Lampichler K, 2021. Prognostic impact of sarcopenia in cirrhotic patients stratified by different severity of portal hypertension. Liver Int 41(4):799-809
Steininger L; Chromy D; Bauer D; Simbrunner B; Binter T; Schwabl P; Schmidbauer C; Trauner M; Gschwantler M; Mandorfer M; Reiberger T, 2021. Direct patient-physician communication via a hepatitis C hotline facilitates treatment initiation in patients with poor adherence. Wien Klin Wochenschr 133(9-10):452-460
Trebicka J; Gu W; de Ledinghen V; Aubé C; Krag A; Praktiknjo M; Castera L; Dumortier J; Bauer DJM; Friedrich-Rust M; Pol S; Grgurevic I; Zheng R; Francque S; Gottfriedovà H; Mustapic S; Sporea I; Berzigotti A; Uschner FE; Simbrunner B; Ronot M; Cassinotto C; Kjaergaard M; Andrade F; Schulz M; Semmler G; Drinkovic IT; Chang J; Brol MJ; Rautou PE; Vanwolleghem T; Strassburg CP; Boursier J; Ferstl PG; Rasmussen DN; Reiberger T; Vilgrain V; Guibal A; Guillaud O; Zeuzem S; Vassord C; Lu X; Vonghia L; Senkerikova R; Popescu A; Margini C; Wang W; Thiele M; Jansen C, 2021. Two-dimensional shear wave elastography predicts survival in advanced chronic liver disease. Gut.
Eder M; Omic H; Gorges J; Badt F; Kikic Z; Saemann MD; Tong A; Bauer D; Semmler G; Reiberger T; Lagler H; Scheiner B, 2021. Influenza vaccination uptake and factors influencing vaccination decision among patients with chronic kidney or liver disease. PLoS One 16(4):e0249785
Costa D; Simbrunner B; Jachs M; Hartl L; Bauer D; Paternostro R; Schwabl P; Scheiner B; Stättermayer AF; Pinter M; Trauner M; Mandorfer M; Reiberger T, 2021. Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality. J Hepatol 74(4):819-828
Hartl L; Jachs M; Desbalmes C; Schaufler D; Simbrunner B; Paternostro R; Schwabl P; Bauer DJM; Semmler G; Scheiner B; Bucsics T; Eigenbauer E; Marculescu R; Szekeres T; Peck-Radosavljevic M; Kastl S; Trauner M; Mandorfer M; Reiberger T, 2021. The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomes. Hepatol Int 15(5):1160-1173
Balcar L; Semmler G; Pomej K; Simbrunner B; Bauer D; Hartl L; Jachs M; Paternostro R; Bucsics T; Pinter M; Trauner M; Mandorfer M; Reiberger T; Scheiner B, 2021. Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acute-on-chronic liver failure. United European Gastroenterol J 9(4):427-437
Semmler G; Pomej K; Bauer DJM; Balcar L; Simbrunner B; Binter T; Hartl L; Becker J; Pinter M; Quehenberger P; Trauner M; Mandorfer M; Lisman T; Reiberger T; Scheiner B, 2021. Safety of direct oral anticoagulants in patients with advanced liver disease. Liver Int 41(9):2159-2170
Jachs M; Binter T; Chromy D; Schalk H; Pichler K; Bauer D; Simbrunner B; Hartl L; Schmidbauer C; Mayer F; Strassl R; Mandorfer M; Gschwantler M; Reiberger T, 2021. Outcomes of an HCV elimination program targeting the Viennese MSM population. Wien Klin Wochenschr 133(13-14):635-640
Hartl L; Semmler G; Hofer BS; Schirwani N; Jachs M; Simbrunner B; Bauer DJM; Binter T; Pomej K; Pinter M; Trauner M; Mandorfer M; Reiberger T; Scheiner B, 2021. COVID-19-Related Downscaling of In-Hospital Liver Care Decreased Patient Satisfaction and Increased Liver-Related Mortality. Hepatol Commun 5(10):1660-1675
Mandorfer M; Turon F; Lens S; Baiges A; García-Criado Á; Darnell A; Belmonte E; Ferrusquía-Acosta J; Magaz M; Perez-Campuzano V; Olivas P; Bauer D; Casanovas G; Torres F; Mariño Z; Forns X; Hernández-Gea V; García-Pagán JC, 2021. Risk of non-tumoural portal vein thrombosis in patients with HCV-induced cirrhosis after sustained virological response. Liver Int 41(12):2954-2964
Jachs M; Hartl L; Simbrunner B; Bauer D; Paternostro R; Scheiner B; Schwabl P; Stättermayer AF; Pinter M; Eigenbauer E; Quehenberger P; Trauner M; Reiberger T; Mandorfer M, 2021. Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and Death. Clin Gastroenterol Hepatol.
Königshofer P; Hofer BS; Brusilovskaya K; Simbrunner B; Petrenko O; Wöran K; Herac M; Stift J; Lampichler K; Timelthaler G; Bauer D; Hartl L; Robl B; Sibila M; Podesser BK; Oberhuber G; Schwabl P; Mandorfer M; Trauner M; Reiberger T, 2021. Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies. Hepatology.
Paternostro R; Becker J; Hofer BS; Panagl V; Schiffke H; Simbrunner B; Semmler G; Schwabl P; Scheiner B; Bucsics T; Bauer D; Binter T; Trauner M; Mandorfer M; Reiberger T, 2021. The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices. Dig Liver Dis.
Semmler G; Meyer EL; Kozbial K; Schwabl P; Hametner-Schreil S; Zanetto A; Bauer D; Chromy D; Simbrunner B; Scheiner B; Stättermayer AF; Pinter M; Schöfl R; Russo FP; Greenfield H; Schwarz M; Schwarz C; Gschwantler M; Alonso López S; Manzano ML; Ahumada A; Bañares R; Pons M; Rodriguez-Tajes S; Genesca J; Lens S; Trauner M; Ferenci P; Reiberger T; Mandorfer M, 2021. HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease. J Hepatol.
Scheiner B; Semmler G; Maurer F; Schwabl P; Bucsics TA; Paternostro R; Bauer D; Simbrunner B; Trauner M; Mandorfer M; Reiberger T, 2020. Prevalence of and risk factors for anaemia in patients with advanced chronic liver disease. Liver Int 40(1):194-204
Chromy D; Schmidt R; Mandorfer M; Lang GF; Bauer D; Schwabl P; Popow-Kraupp T; Reiberger T; Mayer F, 2020. Hepatitis C Virus RNA Is Commonly Detectable in Rectal and Nasal Fluids of Patients With High Viremia. Clin Infect Dis 71(5):1292-1299
Scheiner B; Stättermayer AF; Schwabl P; Bucsics T; Paternostro R; Bauer D; Simbrunner B; Schmidt R; Marculescu R; Ferlitsch A; Peck-Radosavljevic M; Pinter M; Trauner M; Reiberger T; Ferenci P; Mandorfer M, 2020. Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension. Liver Int 40(2):393-404
Paternostro R; Kapzan L; Mandorfer M; Schwarzer R; Benedikt S; Viveiros A; Bauer D; Ferlitsch M; Zoller H; Trauner M; Ferlitsch A, 2020. Anemia and iron deficiency in compensated and decompensated cirrhosis: Prevalence and impact on clinical outcomes. J Gastroenterol Hepatol 35(9):1619-1627
Simbrunner B; Marculescu R; Scheiner B; Schwabl P; Bucsics T; Stadlmann A; Bauer DJM; Paternostro R; Eigenbauer E; Pinter M; Stättermayer AF; Trauner M; Mandorfer M; Reiberger T, 2020. Non-invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease. Liver Int 40(7):1713-1724
Semmler G; Wöran K; Scheiner B; Unger LW; Paternostro R; Stift J; Schwabl P; Bucsics T; Bauer D; Simbrunner B; Stättermayer AF; Pinter M; Trauner M; Reiberger T; Mandorfer M, 2020. Novel reliability criteria for controlled attenuation parameter assessments for non-invasive evaluation of hepatic steatosis. United European Gastroenterol J 8(3):321-331
Brusilovskaya K; Königshofer P; Lampach D; Szodl A; Supper P; Bauer D; Beer A; Stift J; Timelthaler G; Oberhuber G; Podesser BK; Seif M; Zinober K; Rohr-Udilova N; Trauner M; Reiberger T; Schwabl P, 2020. Soluble guanylyl cyclase stimulation and phosphodiesterase-5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct-ligated rats. United European Gastroenterol J 8(10):1174-1185
Pomej K; Scheiner B; Park D; Bauer D; Balcar L; Meischl T; Mandorfer M; Reiberger T; Müller C; Trauner M; Pinter M, 2020. Vascular Complications in Patients with Hepatocellular Carcinoma Treated with Sorafenib. Cancers (Basel) 12.
Wöran K; Semmler G; Jachs M; Simbrunner B; Bauer DJM; Binter T; Pomej K; Stättermayer AF; Schwabl P; Bucsics T; Paternostro R; Lampichler K; Pinter M; Trauner M; Mandorfer M; Stift J; Reiberger T; Scheiner B, 2020. Clinical Course of Porto-Sinusoidal Vascular Disease Is Distinct From Idiopathic Noncirrhotic Portal Hypertension. Clin Gastroenterol Hepatol.
Simbrunner B; Semmler G; Stadlmann A; Scheiner B; Schwabl P; Paternostro R; Bucsics T; Bauer D; Eigenbauer E; Pinter M; Stättermayer AF; Quehenberger P; Marculescu R; Trauner M; Mandorfer M; Reiberger T, 2020. Vitamin A levels reflect disease severity and portal hypertension in patients with cirrhosis. Hepatol Int 14(6):1093-1103
Paternostro R; Lampichler K; Bardach C; Asenbaum U; Landler C; Bauer D; Mandorfer M; Schwarzer R; Trauner M; Reiberger T; Ferlitsch A, 2019. The value of different CT-based methods for diagnosing low muscle mass and predicting mortality in patients with cirrhosis. Liver Int 39(12):2374-2385
Unger LW; Forstner B; Schneglberger S; Muckenhuber M; Eigenbauer E; Bauer D; Scheiner B; Mandorfer M; Trauner M; Reiberger T, 2019. Guideline-conform statin use reduces overall mortality in patients with compensated liver disease. Sci Rep 9(1):11674
Simbrunner B; Röthenbacher A; Haslacher H; Bauer D; Chromy D; Bucsics T; Schwabl P; Paternostro R; Scheiner B; Trauner M; Mandorfer M; Schwarzinger I; Reiberger T, 2019. Ascitic fluid polymorphic nuclear cell count impacts on outcome of cirrhotic patients with ascites. United European Gastroenterol J 7(5):651-661
Chromy D; Mandorfer M; Bucsics T; Schwabl P; Bauer D; Scheiner B; Schmidbauer C; Lang GF; Szekeres T; Ferenci P; Trauner M; Reiberger T, 2019. Prevalence and Predictors of Hepatic Steatosis in Patients with HIV/HCV Coinfection and the Impact of HCV Eradication. AIDS Patient Care STDS 33(5):197-206
Semmler G; Simbrunner B; Scheiner B; Schwabl P; Paternostro R; Bucsics T; Stättermayer AF; Bauer D; Pinter M; Ferenci P; Trauner M; Mandorfer M; Reiberger T, 2019. Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertension. J Gastroenterol Hepatol 34(12):2164-2172
Mandorfer M; Scheiner B; Stättermayer AF; Schwabl P; Paternostro R; Bauer D; Schaefer B; Zoller H; Peck-Radosavljevic M; Trauner M; Reiberger T; Ferenci P; Ferlitsch A, 2018. Impact of patatin-like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension. Aliment Pharmacol Ther 48(4):451-459
Schwabl P; Brusilovskaya K; Supper P; Bauer D; Königshofer P; Riedl F; Hayden H; Fuchs CD; Stift J; Oberhuber G; Aschauer S; Bonderman D; Gnad T; Pfeifer A; Uschner FE; Trebicka J; Rohr-Udilova N; Podesser BK; Peck-Radosavljevic M; Trauner M; Reiberger T, 2018. The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats. Sci Rep 8(1):9372
Mandorfer M; Schwabl P; Paternostro R; Pomej K; Bauer D; Thaler J; Ay C; Quehenberger P; Fritzer-Szekeres M; Peck-Radosavljevic M; Trauner M; Reiberger T; Ferlitsch A, 2018. Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity. Aliment Pharmacol Ther 47(7):980-988
Publication list retrieved from NCBI using ImpactPubs
.